Cardiovascular diseases such as congestive heart failure are usually long-term and cost-incurring conditions. Incidence of cardiac disorders accounts for over 32 percent of all deaths worldwide, as per WHO. Lifestyle-related diseases and the aging population function as two primary drivers for cardiovascular diseases globally.
With the repeated assessment of circulatory function over time, perturbations with regards to physiological stress such as tissue hypoxia associated with surgery can be easily monitored and prevent cases of morbidity or mortality. This factor justifiably drives demand for hemodynamic monitoring systems and is followed by repeated and advanced technological modifications to pre-existing monitoring systems.
To remain ahead of your competitors, request for a sample @ https://www.persistencemarketresearch.com/samples/4396
The growth of hemodynamic monitoring systems is supported by rising health expenditure by governments as well as private players, especially in developed economies. Growth is set to lead to management of cardiac output with minimal continuous observation and a patient- and physician-adaptable interface to provide feedback and alerts predicting hemodynamic instability.
Although the market has witnessed the advancement of technology in terms of hemodynamic monitoring, the lack of trained professionals for the operation of instruments poses a restrictive factor for market growth.
Opportunistic growth awaits throughout the forecast period in terms of new developments in non-invasive hemodynamic monitoring. Apart from this, the emergence of implants for hemodynamic monitoring is expected to enhance the adoption of remote monitoring in personal and home care settings. The increasing patient population in emerging economies is expected to drive demand for hemodynamic monitoring systems over the forecast period.
Considering consolation activities in the global market, mergers and acquisitions have emerged as one of the key growth strategies by market players. Prominent players are strengthening their product ranges through acquisitions and reaching out to key as well as emerging markets.
In September 2021, ICU Medical, Inc. and Smiths Group plc announced that ICU Medical has committed to acquire Smiths Medical division in a transaction that is more than the existing proposed sale of Smiths Medical to Trulli Bidco Limited.
Key Takeaways from Market Study
By type, non-invasive hemodynamic monitoring systems are expected to hold over 52% market value share by the end of 2031.
Based on product, hemodynamic monitors are leading with 63.8% market share in 2020, owing to advancements in digitally integrated health solutions devices.
Based on modality, portable hemodynamic monitors are leading with 54.3% market share, due to high prevalence of cardiovascular diseases worldwide.
Hospitals dominated the end user segment with a share of around 45.2% in 2020, because of effective close patient monitoring in ICU settings.
By region, North America is slated to be the largest leading market with a value share of 29.8% by the end of the forecast period.
Growing prevalence of cardiovascular disorders and diverse applications of hemodynamic monitoring systems in critically-ill patients are anticipated to boost market expansion, says an analyst of Persistence Market Research.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/4396
Edwards Lifesciences Corporation
General Electric Company
Cheetah medical Inc.
Koninklijke Philips N.V.
Osypka Medical GmbH
Schwarzer Cardiotek GmbH
Deltex medical group
Acquisitions, mergers, expansions, and product launches are key strategies adopted by manufacturers and integrators for development of advanced technology integrated systems.
In June 2021, Edwards Lifesciences announced that Acumen Hypotension Prediction Index (HPI) software with the Acumen IQ finger cuff received U.S. Food and Drug Administration clearance. This is the first non-invasive solution that unlocks Acumen HPI software and uses machine learning to alert clinicians of the likelihood a patient towards hypotension or low blood pressure.
In November 2019, ICU Medical Inc. acquired Pursuit Vascular, Inc. Pursuits primary product is the ClearGuard® HD Cap, used for the maintenance of hemodynamic catheters.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the hemodynamic monitoring systems market in its latest study, presenting historical demand assessment of 2016 2020 and projections for 2021 2031.
For in-depth competitive analysis, buy now @ https://www.persistencemarketresearch.com/checkout/4396
The research study is based on the type (invasive, minimally-invasive, and non-invasive), product (disposable and monitor), modality (floor/wall-mounted, benchtop, and portable), and end user (hospitals, specialty clinics, cath labs, ambulatory care settings, and home-based care settings), across seven key regions of the world.
Trending Reports of PMR-
Holter Monitoring Systems Market-
Global Holter Monitoring Systems Market evenue & valuation from the market in the region is expected to expand at a CAGR of 5.2% over the forecast period.
Alcohol Breathalyzer Drug Testing Equipment Market-
Alcohol Breathalyzer Equipment Market is projected to expand at a CAGR of 6.9% during the forecast period 2018-2026.
Kidney Dialysis Equipment Market-
Global Kidney Dialysis Equipment Market forecasts the market revenues to reach US$ 25.128 Bn by 2024 end and is projected to grow at a CAGR of 6.5% through 2024.
Patient Positioning Equipment Market-
The global patient positioning equipment market is anticipated to grow at a moderate pace and is poised to register a CAGR of 3.2% over the period of 2017-2025 to reach a value of US$ 2 Bn.
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Persistence Market Research
Address 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. +1-646-568-7751
USA-Canada Toll-free +1 800-961-0353